Industry Insights & Technical Resources
Regulatory updates, testing methodologies, and strategic perspectives from our scientific and regulatory affairs teams. Written for R&D directors, regulatory professionals, and procurement decision-makers.
Understanding FDA's Updated Preclinical Testing Requirements
The FDA's recent guidance updates have significant implications for preclinical study design. We break down the key changes affecting contract testing laboratories and their sponsors.
Species Selection Guide for Preclinical Safety Studies
Choosing the right animal model is one of the most consequential decisions in preclinical development. This guide covers key considerations for species selection across therapeutic areas.
The Future of Cosmetic Safety Testing: Integrated Approaches
As regulatory frameworks evolve, cosmetic safety testing is moving toward integrated strategies that combine in vitro, in silico, and targeted in vivo methods for comprehensive safety assessment.
GLP Compliance: Essential Requirements for Veterinary Product Development
Good Laboratory Practice compliance is non-negotiable for veterinary product approval. This article outlines the critical GLP requirements specific to animal health product development.
Advances in Rodent Models for Pharmaceutical Research
Recent advances in rodent model development are expanding the utility of these essential preclinical tools. We review the latest developments in genetically modified and disease-specific models.
Global Regulatory Harmonization: Impact on Contract Testing
International efforts to harmonize regulatory requirements are reshaping how contract testing laboratories design studies for global submissions. Here's what sponsors need to know.